Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
193.2 USD | -0.48% | +0.53% | -25.35% |
Apr. 23 | Alzheimer's drug adoption in US slowed by doctors' skepticism | RE |
Apr. 19 | Needham Adjusts Price Target on Biogen to $294 From $300 | MT |
Financials (USD)
Sales 2024 * | 9.46B | Sales 2025 * | 9.51B | Capitalization | 28.08B |
---|---|---|---|---|---|
Net income 2024 * | 1.89B | Net income 2025 * | 2.2B | EV / Sales 2024 * | 3.25 x |
Net Debt 2024 * | 2.7B | Net Debt 2025 * | 289M | EV / Sales 2025 * | 2.98 x |
P/E ratio 2024 * |
14.7
x | P/E ratio 2025 * |
12.8
x | Employees | 7,570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.34% |
Latest transcript on Biogen Inc.
1 day | -0.48% | ||
1 week | -1.01% | ||
Current month | -10.41% | ||
1 month | -10.85% | ||
3 months | -23.24% | ||
6 months | -23.76% | ||
Current year | -25.35% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 22-11-13 | |
Director of Finance/CFO | 60 | 20-08-14 | |
Nicole Murphy
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 09-12-31 |
William Hawkins
BRD | Director/Board Member | 70 | 19-06-18 |
Caroline Dorsa
CHM | Chairman | 64 | 10-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 1 M€ | 0.00% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 14,021 M€ | +3.95% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 194.1 | -0.14% | 1,119,536 |
24-04-19 | 194.4 | +2.03% | 1,599,713 |
24-04-18 | 190.5 | -0.85% | 1,512,073 |
24-04-17 | 192.2 | -1.53% | 1,320,707 |
24-04-16 | 195.2 | -0.84% | 872,004 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.35% | 28.22B | |
-2.68% | 85.68B | |
+4.08% | 41.4B | |
+54.31% | 24.64B | |
-4.52% | 16.98B | |
-42.09% | 13.29B | |
-17.77% | 11.66B | |
-12.10% | 11.65B | |
+0.75% | 8.18B | |
+3.32% | 7.78B |
- Stock Market
- Equities
- BIIB Stock